The global Polypeptide Drug market was valued at US$ 689 million in 2023 and is anticipated to reach US$ 1037.4 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.

Polypeptide Drug Market

Polypeptide antibiotic. Polypeptide antibiotics are a chemically diverse class of anti-infective and antitumor antibiotics containing non-protein polypeptide chains. Examples of this class include actinomycin, bacitracin, colistin, and polymyxin B. Actinomycin-D has found use in cancer chemotherapy.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Polypeptide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polypeptide Drug.

Report Scope

The Polypeptide Drug market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polypeptide Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Polypeptide Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Polypeptide Drug Market Report

Report Metric	Details
Report Name	Polypeptide Drug Market
Accounted market size in 2023	US$ 689 million
Forecasted market size in 2030	US$ 1037.4 million
CAGR	6.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Injection Nasal Administration Lung Administration Oral Administration Transdermal Administration
Segment by Application	Immunity Regulating Medicine (Allergy Infection and Immune) Digestive System Drugs (Gastrointestinal Type) Bone and Connective Tissue Types (Thyroid hormones Drug) Gynecologic or Obstetric Drug Tumor Drug Urinary System Drug Metabolic Drug (Insulin and Other Hypoglycemic Agents)
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novartis, Merck Serono, Ferring Pharmaceuticals, Ipsen PHarma Biotech, Lilly, Asahi Kasei, AstraZeneca, SciClone Pharmaceuticals, Takeda, Roche, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polypeptide Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Polypeptide Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Polypeptide Drug Market growing?

Ans: The Polypeptide Drug Market witnessing a CAGR of 6.4% during the forecast period 2024-2030.

What is the Polypeptide Drug Market size in 2030?

Ans: The Polypeptide Drug Market size in 2030 will be US$ 1037.4 million.

Who are the main players in the Polypeptide Drug Market report?

Ans: The main players in the Polypeptide Drug Market are Novartis, Merck Serono, Ferring Pharmaceuticals, Ipsen PHarma Biotech, Lilly, Asahi Kasei, AstraZeneca, SciClone Pharmaceuticals, Takeda, Roche, Sanofi

What are the Application segmentation covered in the Polypeptide Drug Market report?

Ans: The Applications covered in the Polypeptide Drug Market report are Immunity Regulating Medicine (Allergy Infection and Immune), Digestive System Drugs (Gastrointestinal Type), Bone and Connective Tissue Types (Thyroid hormones Drug), Gynecologic or Obstetric Drug, Tumor Drug, Urinary System Drug, Metabolic Drug (Insulin and Other Hypoglycemic Agents)

What are the Type segmentation covered in the Polypeptide Drug Market report?

Ans: The Types covered in the Polypeptide Drug Market report are Injection, Nasal Administration, Lung Administration, Oral Administration, Transdermal Administration

1 Polypeptide Drug Market Overview

1.1 Product Overview and Scope of Polypeptide Drug

1.2 Polypeptide Drug Segment by Type

1.2.1 Global Polypeptide Drug Market Value Comparison by Type (2024-2030)

1.2.2 Injection

1.2.3 Nasal Administration

1.2.4 Lung Administration

1.2.5 Oral Administration

1.2.6 Transdermal Administration

1.3 Polypeptide Drug Segment by Application

1.3.1 Global Polypeptide Drug Market Value by Application: (2024-2030)

1.3.2 Immunity Regulating Medicine (Allergy Infection and Immune)

1.3.3 Digestive System Drugs (Gastrointestinal Type)

1.3.4 Bone and Connective Tissue Types (Thyroid hormones Drug)

1.3.5 Gynecologic or Obstetric Drug

1.3.6 Tumor Drug

1.3.7 Urinary System Drug

1.3.8 Metabolic Drug (Insulin and Other Hypoglycemic Agents)

1.4 Global Polypeptide Drug Market Size Estimates and Forecasts

1.4.1 Global Polypeptide Drug Revenue 2019-2030

1.4.2 Global Polypeptide Drug Sales 2019-2030

1.4.3 Global Polypeptide Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Polypeptide Drug Market Competition by Manufacturers

2.1 Global Polypeptide Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global Polypeptide Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Polypeptide Drug Average Price by Manufacturers (2019-2024)

2.4 Global Polypeptide Drug Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Polypeptide Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Polypeptide Drug, Product Type & Application

2.7 Polypeptide Drug Market Competitive Situation and Trends

2.7.1 Polypeptide Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Polypeptide Drug Players Market Share by Revenue

2.7.3 Global Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Polypeptide Drug Retrospective Market Scenario by Region

3.1 Global Polypeptide Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Polypeptide Drug Global Polypeptide Drug Sales by Region: 2019-2030

3.2.1 Global Polypeptide Drug Sales by Region: 2019-2024

3.2.2 Global Polypeptide Drug Sales by Region: 2025-2030

3.3 Global Polypeptide Drug Global Polypeptide Drug Revenue by Region: 2019-2030

3.3.1 Global Polypeptide Drug Revenue by Region: 2019-2024

3.3.2 Global Polypeptide Drug Revenue by Region: 2025-2030

3.4 North America Polypeptide Drug Market Facts & Figures by Country

3.4.1 North America Polypeptide Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Polypeptide Drug Sales by Country (2019-2030)

3.4.3 North America Polypeptide Drug Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Polypeptide Drug Market Facts & Figures by Country

3.5.1 Europe Polypeptide Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Polypeptide Drug Sales by Country (2019-2030)

3.5.3 Europe Polypeptide Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Polypeptide Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Polypeptide Drug Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Polypeptide Drug Sales by Country (2019-2030)

3.6.3 Asia Pacific Polypeptide Drug Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Polypeptide Drug Market Facts & Figures by Country

3.7.1 Latin America Polypeptide Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Polypeptide Drug Sales by Country (2019-2030)

3.7.3 Latin America Polypeptide Drug Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Polypeptide Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Polypeptide Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Polypeptide Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa Polypeptide Drug Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Polypeptide Drug Sales by Type (2019-2030)

4.1.1 Global Polypeptide Drug Sales by Type (2019-2024)

4.1.2 Global Polypeptide Drug Sales by Type (2025-2030)

4.1.3 Global Polypeptide Drug Sales Market Share by Type (2019-2030)

4.2 Global Polypeptide Drug Revenue by Type (2019-2030)

4.2.1 Global Polypeptide Drug Revenue by Type (2019-2024)

4.2.2 Global Polypeptide Drug Revenue by Type (2025-2030)

4.2.3 Global Polypeptide Drug Revenue Market Share by Type (2019-2030)

4.3 Global Polypeptide Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global Polypeptide Drug Sales by Application (2019-2030)

5.1.1 Global Polypeptide Drug Sales by Application (2019-2024)

5.1.2 Global Polypeptide Drug Sales by Application (2025-2030)

5.1.3 Global Polypeptide Drug Sales Market Share by Application (2019-2030)

5.2 Global Polypeptide Drug Revenue by Application (2019-2030)

5.2.1 Global Polypeptide Drug Revenue by Application (2019-2024)

5.2.2 Global Polypeptide Drug Revenue by Application (2025-2030)

5.2.3 Global Polypeptide Drug Revenue Market Share by Application (2019-2030)

5.3 Global Polypeptide Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Novartis

6.1.1 Novartis Corporation Information

6.1.2 Novartis Description and Business Overview

6.1.3 Novartis Polypeptide Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Novartis Polypeptide Drug Product Portfolio

6.1.5 Novartis Recent Developments/Updates

6.2 Merck Serono

6.2.1 Merck Serono Corporation Information

6.2.2 Merck Serono Description and Business Overview

6.2.3 Merck Serono Polypeptide Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Merck Serono Polypeptide Drug Product Portfolio

6.2.5 Merck Serono Recent Developments/Updates

6.3 Ferring Pharmaceuticals

6.3.1 Ferring Pharmaceuticals Corporation Information

6.3.2 Ferring Pharmaceuticals Description and Business Overview

6.3.3 Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Ferring Pharmaceuticals Polypeptide Drug Product Portfolio

6.3.5 Ferring Pharmaceuticals Recent Developments/Updates

6.4 Ipsen PHarma Biotech

6.4.1 Ipsen PHarma Biotech Corporation Information

6.4.2 Ipsen PHarma Biotech Description and Business Overview

6.4.3 Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Ipsen PHarma Biotech Polypeptide Drug Product Portfolio

6.4.5 Ipsen PHarma Biotech Recent Developments/Updates

6.5 Lilly

6.5.1 Lilly Corporation Information

6.5.2 Lilly Description and Business Overview

6.5.3 Lilly Polypeptide Drug Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Lilly Polypeptide Drug Product Portfolio

6.5.5 Lilly Recent Developments/Updates

6.6 Asahi Kasei

6.6.1 Asahi Kasei Corporation Information

6.6.2 Asahi Kasei Description and Business Overview

6.6.3 Asahi Kasei Polypeptide Drug Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Asahi Kasei Polypeptide Drug Product Portfolio

6.6.5 Asahi Kasei Recent Developments/Updates

6.7 AstraZeneca

6.6.1 AstraZeneca Corporation Information

6.6.2 AstraZeneca Description and Business Overview

6.6.3 AstraZeneca Polypeptide Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 AstraZeneca Polypeptide Drug Product Portfolio

6.7.5 AstraZeneca Recent Developments/Updates

6.8 SciClone Pharmaceuticals

6.8.1 SciClone Pharmaceuticals Corporation Information

6.8.2 SciClone Pharmaceuticals Description and Business Overview

6.8.3 SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue and Gross Margin (2019-2024)

6.8.4 SciClone Pharmaceuticals Polypeptide Drug Product Portfolio

6.8.5 SciClone Pharmaceuticals Recent Developments/Updates

6.9 Takeda

6.9.1 Takeda Corporation Information

6.9.2 Takeda Description and Business Overview

6.9.3 Takeda Polypeptide Drug Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Takeda Polypeptide Drug Product Portfolio

6.9.5 Takeda Recent Developments/Updates

6.10 Roche

6.10.1 Roche Corporation Information

6.10.2 Roche Description and Business Overview

6.10.3 Roche Polypeptide Drug Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Roche Polypeptide Drug Product Portfolio

6.10.5 Roche Recent Developments/Updates

6.11 Sanofi

6.11.1 Sanofi Corporation Information

6.11.2 Sanofi Polypeptide Drug Description and Business Overview

6.11.3 Sanofi Polypeptide Drug Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Sanofi Polypeptide Drug Product Portfolio

6.11.5 Sanofi Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Polypeptide Drug Industry Chain Analysis

7.2 Polypeptide Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Polypeptide Drug Production Mode & Process

7.4 Polypeptide Drug Sales and Marketing

7.4.1 Polypeptide Drug Sales Channels

7.4.2 Polypeptide Drug Distributors

7.5 Polypeptide Drug Customers

8 Polypeptide Drug Market Dynamics

8.1 Polypeptide Drug Industry Trends

8.2 Polypeptide Drug Market Drivers

8.3 Polypeptide Drug Market Challenges

8.4 Polypeptide Drug Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Novartis

Merck Serono

Ferring Pharmaceuticals

SciClone Pharmaceuticals

Takeda

Roche

Sanofi

List of Tables

Table 1. Global Polypeptide Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Polypeptide Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Polypeptide Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global Polypeptide Drug Sales (MT) of Key Manufacturers (2019-2024)

Table 5. Global Polypeptide Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Polypeptide Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Polypeptide Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Polypeptide Drug Average Price (USD/MT) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Polypeptide Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Polypeptide Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Polypeptide Drug, Product Type & Application

Table 12. Global Key Manufacturers of Polypeptide Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Polypeptide Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polypeptide Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Polypeptide Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Polypeptide Drug Sales by Region (2019-2024) & (MT)

Table 18. Global Polypeptide Drug Sales Market Share by Region (2019-2024)

Table 19. Global Polypeptide Drug Sales by Region (2025-2030) & (MT)

Table 20. Global Polypeptide Drug Sales Market Share by Region (2025-2030)

Table 21. Global Polypeptide Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Polypeptide Drug Revenue Market Share by Region (2019-2024)

Table 23. Global Polypeptide Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Polypeptide Drug Revenue Market Share by Region (2025-2030)

Table 25. North America Polypeptide Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Polypeptide Drug Sales by Country (2019-2024) & (MT)

Table 27. North America Polypeptide Drug Sales by Country (2025-2030) & (MT)

Table 28. North America Polypeptide Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Polypeptide Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Polypeptide Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Polypeptide Drug Sales by Country (2019-2024) & (MT)

Table 32. Europe Polypeptide Drug Sales by Country (2025-2030) & (MT)

Table 33. Europe Polypeptide Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Polypeptide Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Polypeptide Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Polypeptide Drug Sales by Region (2019-2024) & (MT)

Table 37. Asia Pacific Polypeptide Drug Sales by Region (2025-2030) & (MT)

Table 38. Asia Pacific Polypeptide Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Polypeptide Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Polypeptide Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Polypeptide Drug Sales by Country (2019-2024) & (MT)

Table 42. Latin America Polypeptide Drug Sales by Country (2025-2030) & (MT)

Table 43. Latin America Polypeptide Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Polypeptide Drug Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Polypeptide Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Polypeptide Drug Sales by Country (2019-2024) & (MT)

Table 47. Middle East & Africa Polypeptide Drug Sales by Country (2025-2030) & (MT)

Table 48. Middle East & Africa Polypeptide Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Polypeptide Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Polypeptide Drug Sales (MT) by Type (2019-2024)

Table 51. Global Polypeptide Drug Sales (MT) by Type (2025-2030)

Table 52. Global Polypeptide Drug Sales Market Share by Type (2019-2024)

Table 53. Global Polypeptide Drug Sales Market Share by Type (2025-2030)

Table 54. Global Polypeptide Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Polypeptide Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Polypeptide Drug Revenue Market Share by Type (2019-2024)

Table 57. Global Polypeptide Drug Revenue Market Share by Type (2025-2030)

Table 58. Global Polypeptide Drug Price (USD/MT) by Type (2019-2024)

Table 59. Global Polypeptide Drug Price (USD/MT) by Type (2025-2030)

Table 60. Global Polypeptide Drug Sales (MT) by Application (2019-2024)

Table 61. Global Polypeptide Drug Sales (MT) by Application (2025-2030)

Table 62. Global Polypeptide Drug Sales Market Share by Application (2019-2024)

Table 63. Global Polypeptide Drug Sales Market Share by Application (2025-2030)

Table 64. Global Polypeptide Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Polypeptide Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Polypeptide Drug Revenue Market Share by Application (2019-2024)

Table 67. Global Polypeptide Drug Revenue Market Share by Application (2025-2030)

Table 68. Global Polypeptide Drug Price (USD/MT) by Application (2019-2024)

Table 69. Global Polypeptide Drug Price (USD/MT) by Application (2025-2030)

Table 70. Novartis Corporation Information

Table 71. Novartis Description and Business Overview

Table 72. Novartis Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 73. Novartis Polypeptide Drug Product

Table 74. Novartis Recent Developments/Updates

Table 75. Merck Serono Corporation Information

Table 76. Merck Serono Description and Business Overview

Table 77. Merck Serono Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 78. Merck Serono Polypeptide Drug Product

Table 79. Merck Serono Recent Developments/Updates

Table 80. Ferring Pharmaceuticals Corporation Information

Table 81. Ferring Pharmaceuticals Description and Business Overview

Table 82. Ferring Pharmaceuticals Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 83. Ferring Pharmaceuticals Polypeptide Drug Product

Table 84. Ferring Pharmaceuticals Recent Developments/Updates

Table 85. Ipsen PHarma Biotech Corporation Information

Table 86. Ipsen PHarma Biotech Description and Business Overview

Table 87. Ipsen PHarma Biotech Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 88. Ipsen PHarma Biotech Polypeptide Drug Product

Table 89. Ipsen PHarma Biotech Recent Developments/Updates

Table 90. Lilly Corporation Information

Table 91. Lilly Description and Business Overview

Table 92. Lilly Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 93. Lilly Polypeptide Drug Product

Table 94. Lilly Recent Developments/Updates

Table 95. Asahi Kasei Corporation Information

Table 96. Asahi Kasei Description and Business Overview

Table 97. Asahi Kasei Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 98. Asahi Kasei Polypeptide Drug Product

Table 99. Asahi Kasei Recent Developments/Updates

Table 100. AstraZeneca Corporation Information

Table 101. AstraZeneca Description and Business Overview

Table 102. AstraZeneca Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 103. AstraZeneca Polypeptide Drug Product

Table 104. AstraZeneca Recent Developments/Updates

Table 105. SciClone Pharmaceuticals Corporation Information

Table 106. SciClone Pharmaceuticals Description and Business Overview

Table 107. SciClone Pharmaceuticals Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 108. SciClone Pharmaceuticals Polypeptide Drug Product

Table 109. SciClone Pharmaceuticals Recent Developments/Updates

Table 110. Takeda Corporation Information

Table 111. Takeda Description and Business Overview

Table 112. Takeda Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 113. Takeda Polypeptide Drug Product

Table 114. Takeda Recent Developments/Updates

Table 115. Roche Corporation Information

Table 116. Roche Description and Business Overview

Table 117. Roche Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 118. Roche Polypeptide Drug Product

Table 119. Roche Recent Developments/Updates

Table 120. Sanofi Corporation Information

Table 121. Sanofi Description and Business Overview

Table 122. Sanofi Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 123. Sanofi Polypeptide Drug Product

Table 124. Sanofi Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Polypeptide Drug Distributors List

Table 128. Polypeptide Drug Customers List

Table 129. Polypeptide Drug Market Trends

Table 130. Polypeptide Drug Market Drivers

Table 131. Polypeptide Drug Market Challenges

Table 132. Polypeptide Drug Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Polypeptide Drug

Figure 2. Global Polypeptide Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Polypeptide Drug Market Share by Type in 2023 & 2030

Figure 4. Injection Product Picture

Figure 5. Nasal Administration Product Picture

Figure 6. Lung Administration Product Picture

Figure 7. Oral Administration Product Picture

Figure 8. Transdermal Administration Product Picture

Figure 9. Global Polypeptide Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Polypeptide Drug Market Share by Application in 2023 & 2030

Figure 11. Immunity Regulating Medicine (Allergy Infection and Immune)

Figure 12. Digestive System Drugs (Gastrointestinal Type)

Figure 13. Bone and Connective Tissue Types (Thyroid hormones Drug)

Figure 14. Gynecologic or Obstetric Drug

Figure 15. Tumor Drug

Figure 16. Urinary System Drug

Figure 17. Metabolic Drug (Insulin and Other Hypoglycemic Agents)

Figure 18. Global Polypeptide Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Polypeptide Drug Market Size (2019-2030) & (US$ Million)

Figure 20. Global Polypeptide Drug Sales (2019-2030) & (MT)

Figure 21. Global Polypeptide Drug Average Price (USD/MT) & (2019-2030)

Figure 22. Polypeptide Drug Report Years Considered

Figure 23. Polypeptide Drug Sales Share by Manufacturers in 2023

Figure 24. Global Polypeptide Drug Revenue Share by Manufacturers in 2023

Figure 25. The Global 5 and 10 Largest Polypeptide Drug Players: Market Share by Revenue in 2023

Figure 26. Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 27. Global Polypeptide Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 28. North America Polypeptide Drug Sales Market Share by Country (2019-2030)

Figure 29. North America Polypeptide Drug Revenue Market Share by Country (2019-2030)

Figure 30. U.S. Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Canada Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Europe Polypeptide Drug Sales Market Share by Country (2019-2030)

Figure 33. Europe Polypeptide Drug Revenue Market Share by Country (2019-2030)

Figure 34. Germany Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. France Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. U.K. Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Italy Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Russia Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Asia Pacific Polypeptide Drug Sales Market Share by Region (2019-2030)

Figure 40. Asia Pacific Polypeptide Drug Revenue Market Share by Region (2019-2030)

Figure 41. China Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Japan Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. South Korea Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. India Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Australia Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. China Taiwan Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Indonesia Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Thailand Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Malaysia Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Latin America Polypeptide Drug Sales Market Share by Country (2019-2030)

Figure 51. Latin America Polypeptide Drug Revenue Market Share by Country (2019-2030)

Figure 52. Mexico Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Brazil Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Argentina Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Middle East & Africa Polypeptide Drug Sales Market Share by Country (2019-2030)

Figure 56. Middle East & Africa Polypeptide Drug Revenue Market Share by Country (2019-2030)

Figure 57. Turkey Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. Saudi Arabia Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. UAE Polypeptide Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 60. Global Sales Market Share of Polypeptide Drug by Type (2019-2030)

Figure 61. Global Revenue Market Share of Polypeptide Drug by Type (2019-2030)

Figure 62. Global Polypeptide Drug Price (USD/MT) by Type (2019-2030)

Figure 63. Global Sales Market Share of Polypeptide Drug by Application (2019-2030)

Figure 64. Global Revenue Market Share of Polypeptide Drug by Application (2019-2030)

Figure 65. Global Polypeptide Drug Price (USD/MT) by Application (2019-2030)

Figure 66. Polypeptide Drug Value Chain

Figure 67. Polypeptide Drug Production Process

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Distributors Profiles

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions